USA Orexin Receptor Type 2 Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Orexin Receptor Type 2 market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Orexin Receptor Type 2 market. Detailed analysis of key players, along with key growth strategies adopted by Orexin Receptor Type 2 industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Eisai Co Ltd

    • Merck & Co Inc

    • Idorsia Ltd

    • Yangtze River Pharmaceutical Group

    • Johnson & Johnson

    • Actelion Pharmaceuticals Ltd

    • OptiNose US Inc

    • Evotec AG

    • Heptares Therapeutics Ltd

    By Type:

    • HTL-6641

    • MK-8133

    • Lemborexant

    • OPN-021

    • YNT-185

    • Others

    By End-User:

    • Insomnia

    • Narcolepsy

    • Sleep Disorders

    • Major Depressive Disorder

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Orexin Receptor Type 2 Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Orexin Receptor Type 2 Market Size and Growth Rate of HTL-6641 from 2016 to 2027

      • 1.3.2 USA Orexin Receptor Type 2 Market Size and Growth Rate of MK-8133 from 2016 to 2027

      • 1.3.3 USA Orexin Receptor Type 2 Market Size and Growth Rate of Lemborexant from 2016 to 2027

      • 1.3.4 USA Orexin Receptor Type 2 Market Size and Growth Rate of OPN-021 from 2016 to 2027

      • 1.3.5 USA Orexin Receptor Type 2 Market Size and Growth Rate of YNT-185 from 2016 to 2027

      • 1.3.6 USA Orexin Receptor Type 2 Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Orexin Receptor Type 2 Market Size and Growth Rate of Insomnia from 2016 to 2027

      • 1.4.2 USA Orexin Receptor Type 2 Market Size and Growth Rate of Narcolepsy from 2016 to 2027

      • 1.4.3 USA Orexin Receptor Type 2 Market Size and Growth Rate of Sleep Disorders from 2016 to 2027

      • 1.4.4 USA Orexin Receptor Type 2 Market Size and Growth Rate of Major Depressive Disorder from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Orexin Receptor Type 2 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Orexin Receptor Type 2 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Orexin Receptor Type 2 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Orexin Receptor Type 2 Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Orexin Receptor Type 2 Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Orexin Receptor Type 2 by Major Types

      • 3.4.1 Market Size and Growth Rate of HTL-6641

      • 3.4.2 Market Size and Growth Rate of MK-8133

      • 3.4.3 Market Size and Growth Rate of Lemborexant

      • 3.4.4 Market Size and Growth Rate of OPN-021

      • 3.4.5 Market Size and Growth Rate of YNT-185

      • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of Orexin Receptor Type 2 Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Orexin Receptor Type 2 by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Orexin Receptor Type 2 in Insomnia

      • 4.4.2 Market Size and Growth Rate of Orexin Receptor Type 2 in Narcolepsy

      • 4.4.3 Market Size and Growth Rate of Orexin Receptor Type 2 in Sleep Disorders

      • 4.4.4 Market Size and Growth Rate of Orexin Receptor Type 2 in Major Depressive Disorder

    5 Market Analysis by Regions

    • 5.1 USA Orexin Receptor Type 2 Production Analysis by Regions

    • 5.2 USA Orexin Receptor Type 2 Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Orexin Receptor Type 2 Landscape Analysis

    • 6.1 West USA Orexin Receptor Type 2 Landscape Analysis by Major Types

    • 6.2 West USA Orexin Receptor Type 2 Landscape Analysis by Major End-Users

    7 South USA Orexin Receptor Type 2 Landscape Analysis

    • 7.1 South USA Orexin Receptor Type 2 Landscape Analysis by Major Types

    • 7.2 South USA Orexin Receptor Type 2 Landscape Analysis by Major End-Users

    8 Middle West USA Orexin Receptor Type 2 Landscape Analysis

    • 8.1 Middle West USA Orexin Receptor Type 2 Landscape Analysis by Major Types

    • 8.2 Middle West USA Orexin Receptor Type 2 Landscape Analysis by Major End-Users

    9 Northeast USA Orexin Receptor Type 2 Landscape Analysis

    • 9.1 Northeast USA Orexin Receptor Type 2 Landscape Analysis by Major Types

    • 9.2 Northeast USA Orexin Receptor Type 2 Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Eisai Co Ltd

        • 10.1.1 Eisai Co Ltd Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Merck & Co Inc

        • 10.2.1 Merck & Co Inc Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Idorsia Ltd

        • 10.3.1 Idorsia Ltd Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Yangtze River Pharmaceutical Group

        • 10.4.1 Yangtze River Pharmaceutical Group Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Johnson & Johnson

        • 10.5.1 Johnson & Johnson Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Actelion Pharmaceuticals Ltd

        • 10.6.1 Actelion Pharmaceuticals Ltd Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 OptiNose US Inc

        • 10.7.1 OptiNose US Inc Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Evotec AG

        • 10.8.1 Evotec AG Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Heptares Therapeutics Ltd

        • 10.9.1 Heptares Therapeutics Ltd Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Orexin Receptor Type 2 Market Size and Growth Rate of HTL-6641 from 2016 to 2027

    • Figure USA Orexin Receptor Type 2 Market Size and Growth Rate of MK-8133 from 2016 to 2027

    • Figure USA Orexin Receptor Type 2 Market Size and Growth Rate of Lemborexant from 2016 to 2027

    • Figure USA Orexin Receptor Type 2 Market Size and Growth Rate of OPN-021 from 2016 to 2027

    • Figure USA Orexin Receptor Type 2 Market Size and Growth Rate of YNT-185 from 2016 to 2027

    • Figure USA Orexin Receptor Type 2 Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Orexin Receptor Type 2 Market Size and Growth Rate of Insomnia from 2016 to 2027

    • Figure USA Orexin Receptor Type 2 Market Size and Growth Rate of Narcolepsy from 2016 to 2027

    • Figure USA Orexin Receptor Type 2 Market Size and Growth Rate of Sleep Disorders from 2016 to 2027

    • Figure USA Orexin Receptor Type 2 Market Size and Growth Rate of Major Depressive Disorder from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Orexin Receptor Type 2 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Orexin Receptor Type 2 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Orexin Receptor Type 2 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Orexin Receptor Type 2 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Orexin Receptor Type 2 Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Orexin Receptor Type 2

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Orexin Receptor Type 2 by Different Types from 2016 to 2027

    • Table Consumption Share of Orexin Receptor Type 2 by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of HTL-6641

    • Figure Market Size and Growth Rate of MK-8133

    • Figure Market Size and Growth Rate of Lemborexant

    • Figure Market Size and Growth Rate of OPN-021

    • Figure Market Size and Growth Rate of YNT-185

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Orexin Receptor Type 2 by Different End-Users from 2016 to 2027

    • Table Consumption Share of Orexin Receptor Type 2 by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Insomnia

    • Figure Market Size and Growth Rate of Narcolepsy

    • Figure Market Size and Growth Rate of Sleep Disorders

    • Figure Market Size and Growth Rate of Major Depressive Disorder

    • Table USA Orexin Receptor Type 2 Production by Regions

    • Table USA Orexin Receptor Type 2 Production Share by Regions

    • Figure USA Orexin Receptor Type 2 Production Share by Regions in 2016

    • Figure USA Orexin Receptor Type 2 Production Share by Regions in 2021

    • Figure USA Orexin Receptor Type 2 Production Share by Regions in 2027

    • Table USA Orexin Receptor Type 2 Consumption by Regions

    • Table USA Orexin Receptor Type 2 Consumption Share by Regions

    • Figure USA Orexin Receptor Type 2 Consumption Share by Regions in 2016

    • Figure USA Orexin Receptor Type 2 Consumption Share by Regions in 2021

    • Figure USA Orexin Receptor Type 2 Consumption Share by Regions in 2027

    • Table West USA Orexin Receptor Type 2 Consumption by Types from 2016 to 2027

    • Table West USA Orexin Receptor Type 2 Consumption Share by Types from 2016 to 2027

    • Figure West USA Orexin Receptor Type 2 Consumption Share by Types in 2016

    • Figure West USA Orexin Receptor Type 2 Consumption Share by Types in 2021

    • Figure West USA Orexin Receptor Type 2 Consumption Share by Types in 2027

    • Table West USA Orexin Receptor Type 2 Consumption by End-Users from 2016 to 2027

    • Table West USA Orexin Receptor Type 2 Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Orexin Receptor Type 2 Consumption Share by End-Users in 2016

    • Figure West USA Orexin Receptor Type 2 Consumption Share by End-Users in 2021

    • Figure West USA Orexin Receptor Type 2 Consumption Share by End-Users in 2027

    • Table South USA Orexin Receptor Type 2 Consumption by Types from 2016 to 2027

    • Table South USA Orexin Receptor Type 2 Consumption Share by Types from 2016 to 2027

    • Figure South USA Orexin Receptor Type 2 Consumption Share by Types in 2016

    • Figure South USA Orexin Receptor Type 2 Consumption Share by Types in 2021

    • Figure South USA Orexin Receptor Type 2 Consumption Share by Types in 2027

    • Table South USA Orexin Receptor Type 2 Consumption by End-Users from 2016 to 2027

    • Table South USA Orexin Receptor Type 2 Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Orexin Receptor Type 2 Consumption Share by End-Users in 2016

    • Figure South USA Orexin Receptor Type 2 Consumption Share by End-Users in 2021

    • Figure South USA Orexin Receptor Type 2 Consumption Share by End-Users in 2027

    • Table Middle West USA Orexin Receptor Type 2 Consumption by Types from 2016 to 2027

    • Table Middle West USA Orexin Receptor Type 2 Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Orexin Receptor Type 2 Consumption Share by Types in 2016

    • Figure Middle West USA Orexin Receptor Type 2 Consumption Share by Types in 2021

    • Figure Middle West USA Orexin Receptor Type 2 Consumption Share by Types in 2027

    • Table Middle West USA Orexin Receptor Type 2 Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Orexin Receptor Type 2 Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Orexin Receptor Type 2 Consumption Share by End-Users in 2016

    • Figure Middle West USA Orexin Receptor Type 2 Consumption Share by End-Users in 2021

    • Figure Middle West USA Orexin Receptor Type 2 Consumption Share by End-Users in 2027

    • Table Northeast USA Orexin Receptor Type 2 Consumption by Types from 2016 to 2027

    • Table Northeast USA Orexin Receptor Type 2 Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Orexin Receptor Type 2 Consumption Share by Types in 2016

    • Figure Northeast USA Orexin Receptor Type 2 Consumption Share by Types in 2021

    • Figure Northeast USA Orexin Receptor Type 2 Consumption Share by Types in 2027

    • Table Northeast USA Orexin Receptor Type 2 Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Orexin Receptor Type 2 Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Orexin Receptor Type 2 Consumption Share by End-Users in 2016

    • Figure Northeast USA Orexin Receptor Type 2 Consumption Share by End-Users in 2021

    • Figure Northeast USA Orexin Receptor Type 2 Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Eisai Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai Co Ltd

    • Figure Sales and Growth Rate Analysis of Eisai Co Ltd

    • Figure Revenue and Market Share Analysis of Eisai Co Ltd

    • Table Product and Service Introduction of Eisai Co Ltd

    • Table Company Profile and Development Status of Merck & Co Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co Inc

    • Figure Sales and Growth Rate Analysis of Merck & Co Inc

    • Figure Revenue and Market Share Analysis of Merck & Co Inc

    • Table Product and Service Introduction of Merck & Co Inc

    • Table Company Profile and Development Status of Idorsia Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Idorsia Ltd

    • Figure Sales and Growth Rate Analysis of Idorsia Ltd

    • Figure Revenue and Market Share Analysis of Idorsia Ltd

    • Table Product and Service Introduction of Idorsia Ltd

    • Table Company Profile and Development Status of Yangtze River Pharmaceutical Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Yangtze River Pharmaceutical Group

    • Figure Sales and Growth Rate Analysis of Yangtze River Pharmaceutical Group

    • Figure Revenue and Market Share Analysis of Yangtze River Pharmaceutical Group

    • Table Product and Service Introduction of Yangtze River Pharmaceutical Group

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Actelion Pharmaceuticals Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actelion Pharmaceuticals Ltd

    • Figure Sales and Growth Rate Analysis of Actelion Pharmaceuticals Ltd

    • Figure Revenue and Market Share Analysis of Actelion Pharmaceuticals Ltd

    • Table Product and Service Introduction of Actelion Pharmaceuticals Ltd

    • Table Company Profile and Development Status of OptiNose US Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OptiNose US Inc

    • Figure Sales and Growth Rate Analysis of OptiNose US Inc

    • Figure Revenue and Market Share Analysis of OptiNose US Inc

    • Table Product and Service Introduction of OptiNose US Inc

    • Table Company Profile and Development Status of Evotec AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Evotec AG

    • Figure Sales and Growth Rate Analysis of Evotec AG

    • Figure Revenue and Market Share Analysis of Evotec AG

    • Table Product and Service Introduction of Evotec AG

    • Table Company Profile and Development Status of Heptares Therapeutics Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Heptares Therapeutics Ltd

    • Figure Sales and Growth Rate Analysis of Heptares Therapeutics Ltd

    • Figure Revenue and Market Share Analysis of Heptares Therapeutics Ltd

    • Table Product and Service Introduction of Heptares Therapeutics Ltd


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.